This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K et al. The metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circ J 2009; 120: 1640–1645.
Calton EK, Miller VS, Soares MJ . Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin? Eur J Clin Nutr 2013; 6: 485–491.
Shoelson SE, Herrero L, Naaz A . Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169–2180.
Lara-Castro C, Fu Y, Chung BH, Garvey WT . Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007; 18: 263–270.
Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR et al. The metabolic syndrome. Endocr Rev 2008; 29: 777–822.
Savage DB, Petersen KF, Shulman GI . Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 2005; 45: 828–833.
Kawada T . Adiponectin and metabolic syndrome: pathway on the relationship. Eur J Clin Nutr 2013; 67: 896.
Register TC, Divers J, Boqwden DW, Carr JJ, Lenchik L, Wagenknecht LE et al. Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-diabetes heart study. J Clin Endocrinol Metab 2013; 98: 1916–1922.
Dorevitch S, Conroy L, Karadkhele A, Rosul L, Stacewicz-Sapuntzakis M et al. Associations between obesity and asthma in a low-income, urban, minority population. Ann Allergy Asthma Immunol 2009; 110: 340–346.
Tsuboi A, Watanabe M, Kazumi T, Fukuo K . Association of low serum iron levels with low grade chronic inflammation and hyperadiponectinemia in community- living elderly women. J Atheroscler Thromb 2013;, e-pub ahead of print April 25 2013; http://dx.doi.org/10.5551/jat.16071.
Patel PS, Buras ED, Balasubramanyam A . The role of the immune system in obesity and insulin resistance. J Obes 2013;, e-pub ahead of print March 21 2013; http://dx.doi.org/10.1155/2013/616193.
Flock MR, Rojers CJ, Prabhu KS, Kris-Etherton PM . Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation. Diabetes Metab Rev 2013;, e-pub ahead of print April 16 2013; doi:10.1002/dmrr.2414.
Johnson AM, Olefsky JM . The origins and drivers of insulin resistance. Cell 2013; 152: 673–684.
Korkmaza GG, Altınoglub E, Civelek S, Sozer V, Erdenen F, Tabak O et al. The association of oxidative stress markers with conventional risk factors in the metabolic syndrome. Metabolism 2013; 62: 828–835.
Almeny M . Relationship between energy dense diets and white adipose tissue inflammation in metabolic syndrome. Nutr Res 2013; 33: 1–11.
Matsuzawa Y, Funahashi T, Nakamura T . The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 2011; 18: 629–639.
Matsubara M, Maruoka S, Katayose S . Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87: 2764–2769.
Baratta R, Amato S, Degano C, Farina MG, Patane’ G, Vigneri R et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 2004; 89: 2665–2671.
Hopkins T, Ouchi N, Shibata R, Walsh K . Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007; 74: 11–18.
Tschritter O, Fritsche A, Thamer C, Michael H, Shirkavand F, Fatemeh S et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2005; 52: 239–243.
Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975–981.
Nakashima R, Yamane K, Kamei N, Nakanishi S, Kohno N . Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese–Americans. J Endocrinol Invest 2011; 34: 615–619.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Calton, E., Miller, V. & Soares, M. Response to the letter of Kawada T on adiponectin and the metabolic syndrome. Eur J Clin Nutr 67, 897 (2013). https://doi.org/10.1038/ejcn.2013.105
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2013.105